ASCO
@ASCO
Followers
149K
Following
36K
Media
4K
Statuses
41K
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Alexandria, VA
Joined February 2009
Getting a head start on your 2026 calendar? Don't miss out on our meetings—the ultimate Place to Be to connect with peers, discover groundbreaking cancer research, and gain clinical insights. Where will we see you this year? Let us know in the comments.
3
8
22
🎙 @montypal of @cityofhope and @Lymphoma_Doc of @MDAndersonNews discuss two of the major challenges facing oncologists in 2026 on the latest episode of the #ASCODailyNews Podcast: https://t.co/098nffj1s1
0
2
4
#AM26 Registration and Housing opened to @ASCO members just a few hours ago and 588 members have already booked! I love the advance planners! Can’t wait to see the all of you in Chicago May 29- June 2. Make plans today at https://t.co/NzfJIuYFT1.
0
2
3
Position yourself as a leading voice in oncology, bringing your discoveries to the global dialogue around cancer care: present your work at 2026 ASCO Breakthrough, June 25-27 in Singapore. Submit your abstract by February 24: https://t.co/EaVhCvfm0T
#ASCOBT26
0
2
4
It can be difficult for physicians to identify rare cancers because of how infrequently they appear. In a new editorial for #ASCODailyNews, @VivekSubbiah and @Dr_R_Kurzrock discuss how to improve detection and treatment of rare and ultra-rare cancers: https://t.co/sTOG5nRNIW
1
5
11
🎉In 2026, we’re bringing our LDP to Central & Eastern Europe! This program will allow oncs in the region to connect, collaborate, and develop problem-solving & decision-making skills. Applications are open through March 10, 2026. Learn more & apply: https://t.co/4bKqqM9uQx
0
9
17
Explore the GI26 program to find out which advances in GI cancers will be featured at this year’s symposium: https://t.co/6uXznhG10F If you’re joining us, whether online or in person, early registration closes tomorrow, Dec. 3, so register today: https://t.co/2UNOzZUehb
0
4
11
#ASCOAdvocacy applauds the House for passing the bipartisan Give Kids a Chance Act, which calls for accelerating research and drug development for rare pediatric diseases, including cancer.
The House just unanimously passed the Give Kids a Chance Act to accelerate drug research and development for rare pediatric diseases, including cancer. This commonsense bill will give families of children facing rare diseases much-needed hope.
0
0
5
The 5-year survival rate for chronic myeloid leukemia (CML) has risen from 22% in 1970s to over 70% today, thanks to NCI-led research. Tell your lawmakers to support cancer research funding: https://t.co/aieFBo2J9h
#SaveResearchStopCancer #ASCOAdvocacy
0
0
2
Should be a good time! Some great discussions!
Only 3 weeks left to join the IASLC | @ASCO 2025 NACLC! Don’t miss expert debates, case discussions + networking. Hotel block closes today⏲️. Save 20% w/ code CHICAGO20. Virtual on-demand available. Claim your spot! https://t.co/8GroWSTO25
0
2
4
Grateful to ASCO @ASCO for the wonderful ASCO LDP Education Scholars program 2024-2025. Learnt in depth on Education and Learning principles. Lot of scope to improve Oncology Education. Excellent classmates and Mentors !
1
3
10
The draft guideline update protocol, stages I-IIIa #nsclc update, is now available for open comment. Provide your feedback to us by December 15. Learn more: https://t.co/ZscnoTaKkl
#LungCancer
0
0
2
Like Dr. Vadehra, find your people at #GI26. Early registration closes Dec. 3; register today:
Finding your people in medicine can be hard. But once you’ve got good people in your corner, the journey gets better. Seeing @TimothyJBrownMD is always a highlight of any meeting. I may be biased but I think my group of people is dope and I’m glad to have seen y’all at #GI25.
1
2
6
Read our initial assessment of the 2026 Medicare Hospital Outpatient Payment & Ambulatory Surgical Center final rule. It finalizes updates to hospital payment rates, site-neutral payments, and the inpatient only list: https://t.co/4ibazrOlO2
#ASCOAdvocacy
0
3
8
This November, we were proud to co-host an International Clinical Research Course in Istanbul, Turkey alongside the Turkish Society of Medical Oncology. Thank you to our partners at TSMO for organizing such an important and informative event! #ASCOGlobalImpact
0
5
14
Our CMO @jrgralow joined @NPR to discuss the impact unstable federal funding for cancer research has on the U.S.’s ability to attract & retain talented researchers & physicians. Funding & other challenges threaten to accelerate “brain drain.” https://t.co/ZF8DOB3atd
#ASCOAdvocacy
1
7
14
We are excited to collaborate with our International Cancer Corps colleagues at the Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia! We successfully hosted an MCMC focused on breast cancer management. Thank you to all involved! #ASCOGlobalImpact
0
3
8
The treatment landscape for advanced UC has changed considerably in recent years. For #ASCODailyNews, @tompowles1 and Dr. Catherine Graham discuss EV + pembro's place as standard 1L therapy & the potential for disease progression on avelumab: https://t.co/ZJRIubaRP0
0
1
5
Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today! Due Dec 12th: https://t.co/SdJgKkUMiq
0
2
8
We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact
1
8
26
Read it now! ASCO Expert & @ClevelandClinic medical oncologist Dr. Joel Saltzman shares his insights on new #CancerResearch suggesting #GLP1s may boost survival in #ColonCancer in @EverydayHealth article. Read his full expert perspective: https://t.co/POGHQJJIfe
0
2
4